Green G D, Kembhavi A A, Davies M E, Barrett A J
Biochem J. 1984 Mar 15;218(3):939-46. doi: 10.1042/bj2180939.
Cysteine proteinase inhibitor (CPI) forms from human liver were purified from the tissue homogenate by alkaline denaturation of cysteine proteinases with which they are complexed, acetone fractionation, affinity chromatography on S-carboxymethyl-papain-Sepharose and chromatofocusing. The multiple forms of CPI were shown immunologically to be forms of two proteins, referred to as CPI-A (comprising the forms of relatively acidic pI) and CPI-B (comprising the more basic forms). CPI-A and CPI-B are similar in their Mr of about 12400, considerable stability to pH2, pH11 and 80 degrees C, and tight-binding inhibition of papain, several related cysteine proteinases and dipeptidyl peptidase I. Ki values were determined for papain, human cathepsins B, H and L, and dipeptidyl peptidase I. The affinity of CPI-A for cathepsin B was about 10-fold greater than that of CPI-B, whereas CBI-B showed about 100-fold stronger inhibition of dipeptidyl peptidase I. For all the cysteine proteinases the liver inhibitors were somewhat less tight binding than cystatin. The resemblance of both CPI-A and CPI-B in several respects to egg-white cystatin is discussed. CPI-A seems to correspond to the epithelial inhibitor described previously, and CPI-B to the inhibitor from other cell types [Järvinen & Rinne (1982) Biochim. Biophys. Acta 708, 210-217].
从人肝脏中提取的半胱氨酸蛋白酶抑制剂(CPI),是通过将与其结合的半胱氨酸蛋白酶进行碱性变性、丙酮分级分离、在S-羧甲基木瓜蛋白酶-琼脂糖上进行亲和层析以及层析聚焦,从组织匀浆中纯化得到的。通过免疫学方法显示,CPI的多种形式是两种蛋白质的形式,分别称为CPI-A(包括相对酸性pI的形式)和CPI-B(包括碱性更强的形式)。CPI-A和CPI-B的相对分子质量约为12400,对pH2、pH11和80℃具有相当的稳定性,并且对木瓜蛋白酶、几种相关的半胱氨酸蛋白酶和二肽基肽酶I具有紧密结合抑制作用。测定了木瓜蛋白酶、人组织蛋白酶B、H和L以及二肽基肽酶I的抑制常数(Ki值)。CPI-A对组织蛋白酶B的亲和力比CPI-B大约高10倍,而CPI-B对二肽基肽酶I的抑制作用则强约100倍。对于所有半胱氨酸蛋白酶,肝脏抑制剂的结合亲和力比胱抑素略低。讨论了CPI-A和CPI-B在几个方面与蛋清胱抑素的相似性。CPI-A似乎对应于先前描述的上皮抑制剂,而CPI-B对应于来自其他细胞类型的抑制剂[亚尔维宁和林内(1982年)《生物化学与生物物理学学报》708,210 - 217]。